report that n=2/28 HNSCC tumor samples that presented aberrant heregulin expression comparable to that of HNSCC CTX-resistant cell lines (FaDuCR cells) were resistant to CTX (94). This evidence concerns the gene NRG1 and head and neck squamous cell carcinoma.